Daina Graybosch

Stock Analyst at Leerink Partners

(0)
# 4855
Out of 5,441 analysts
137
Total ratings
Success rate
Average return
24 Stocks
Name Action PT Current % Upside Ratings Updated
XLO Xilio Therapeutics
Initiates Coverage On: Outperform
2
0.68 194.12% 1 Aug 6, 2025
ADAG Adagene
Initiates Coverage On: Outperform
7
2.29 205.68% 1 Aug 6, 2025
SMMT Summit Therapeutics
Initiates Coverage On: Underperform
12
28.23 -57.49% 1 Jun 11, 2025
ITOS ITeos Therapeutics
Downgrades: Market Perform
47 9
10.11 -10.98% 8 May 14, 2025
AFMD Affimed
Downgrades: Market Perform
5 1
n/a n/a 8 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 5
5 0% 6 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
136 119
80.06 48.64% 19 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
11 2
1.52 31.58% 6 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
60 20
5.63 255.24% 8 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 39
69.11 -43.57% 5 Mar 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
75 45
22.48 100.18% 10 Feb 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 14
0.49 2757.14% 4 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
62 10
0.94 963.83% 7 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 9
2.06 336.89% 10 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 38
9.17 314.39% 2 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
30 8
3.47 130.55% 4 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
223 224
109.29 104.96% 16 Jul 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
2 1400% 1 Jul 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
21 7
7.12 -1.69% 4 Jun 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 17
1.18 1340.68% 3 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
25 2
5.87 -69.34% 6 Apr 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 9
1.49 504.03% 4 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 6
n/a n/a 2 Apr 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
68
n/a n/a 1 Dec 11, 2019